None listed
Conditions
Brief summary
The purpose of this study is to identify whether spinal analgesia with intrathecal morphine alone is superior to spinal analgesia with intrathecal morphine combined with intrathecal clonidine and bupivacaine for patients undergoing major abdominal surgery. Who is it for? The study will include adult patients undergoing liver and pancreatic resection surgery. This is a retrospective study to test the hypothesis that the intrathecal morphine combined with clonidine and bupivacaine results in reduced postoperative opioid use and enhanced postoperative analgesia and recovery in patients undergoing major liver and pancreatic resections using a standardized enhanced recovery after surgery (ERAS) protocol. Study details The aim of this study is to quantify the cumulative oral morphine equivalent daily dose in milligrams (oMEDD) in the postoperative period and evaluate maximum pain scores at rest and on movement after surgery. It is hoped that this study will be hypothesis generating and provide valuable data for power calculations for future studies on evaluating the use of intrathecal morphine in patients undergoing major liver and pancreatic surgery.
Interventions
This is a retrospective analysis of intrathecal analgesia in adult patients who underwent liver and pancreatic resection between January 2010 and June 2021 using a standardized enhanced recovery after surgery protocol. The enhanced recovery after surgery protocol was introduced across all hospitals in January 2010. We will compare patients who received intrathecal morphine only to those patients who received intrathecal morphine in combination with intrathecal clonidine and bupivacaine. Patients who underwent surgery at three university teaching hospitals will be included. Austin Hospital, is a university hospital in Melbourne, Australia with a dedicated high volume hepato-pancreatic-biliary and liver transplant centre. Knox Private and Warringal Private Hospitals are teaching hospitals with expertise in major hepato-pancreatic-biliary surgery. Eligible patients were identified by International Statistical Classification of Diseases (ICD) codes that included the following surgical categories: i.) excision of lesion of liver ii.) segmental resection of liver iii.) lobectomy of liver, iv.) trisegmental resection of liver v.) Whipples procedure vi). Distal pancreatectomy with or without splenectomy vii). Other pancreatic resection (total or central pancreatectomy) Patients will be followed-up until hospital discharge from their index admission. As this is a retrospective study, there is no patient involvement.
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria will be 1. Patients who underwent liver surgery will be identified as candidates for this study using International Statistical Classification of Diseases (ICD) codes including but not limited to excision of lesion of liver, lobectomy of liver, segmental resection of liver. 2. Patients undergoing pancreatic surgery will be identified using ICD codes for the following surgical categories: Whipple’s procedure, total pancreatectomy, central pancreatectomy, and distal pancreatectomy with or without splenectomy. Patients will be included in the study if they were older than 18 years old, underwent major liver or pancreatic surgery as listed previously, and received either intrathecal morphine alone or intrathecal morphine in combination with intrathecal clonidine and bupivacaine.
Exclusion criteria
We will exclude the following patients 1. Patients receiving epidural analgesia 2. Patients undergoing liver or pancreatic surgery secondary to other procedures 3. Patients with a history of chronic pain disorder or chronic opioid use (>60mg oral morphine equivalent daily).